Related Experiment Video
Updated: Jul 15, 2026

05:49
Use of Magnetic Resonance Imaging and Biopsy Data to Guide Sampling Procedures for Prostate Cancer Biobanking
Published on: October 10, 2019
Prostate cancer in Maiduguri
K T Yawe1, M B Tahir, H A Nggada
1Department of Surgery, University of Maiduguri Teaching Hospital, Maiduguri. yterna@yahoo.com
West African Journal of Medicine
|April 4, 2007
Summary
Prostate cancer is increasing in Black men, with many presenting late in North-eastern Nigeria. Early screening and prompt investigation of prostatism symptoms in men over 50 are crucial for timely prostate cancer diagnosis.
Area of Science:
- Oncology
- Urology
- Public Health
Background:
- Prostate cancer is a significant global health concern, with rising incidence in Black populations.
- Limited data exists on prostate cancer demographics and clinical presentation in North-eastern Nigeria.
- This study addresses the scarcity of information on prostate cancer in the region.
Purpose of the Study:
- To describe the clinico-pathological features of prostate cancer in North-eastern Nigeria.
- To evaluate the management strategies employed for prostate cancer patients.
- To provide insights into the challenges and outcomes of prostate cancer care in the region.
Main Methods:
- Retrospective review of clinical records and histopathological slides of prostate cancer patients from 1987 to 2004.
- Inclusion of data from the hospital's cancer registry for comprehensive analysis.
- Utilized digital rectal examination (DRE), ultrasound (USS), and prostate-specific antigen (PSA) tests for diagnosis, confirmed by trucut prostatic biopsy.
Main Results:
- Prostate cancer represented 6.15% of all cancers diagnosed, affecting 165 patients.
- The majority of patients (56%) were 65 years or younger, presenting with symptoms mimicking benign prostatic hypertrophy (BPH).
- Most cases were advanced at diagnosis; subcapsular orchidectomy was the common palliative treatment, with poor follow-up rates (26% at 3 years).
Conclusions:
- Prostate cancer should be suspected in men aged 50 and above with symptoms of prostatism.
- Prompt investigation and diagnosis are essential due to late presentation.
- Aggressive screening programs for men in this age group are recommended to facilitate early detection.
